Tiny Zymeworks Snags $1.4B+ R&D Deal With Drug Giant Johnson & Johnson Post author:Sam Post published:November 12, 2017 Post category:BioPharma There’s nothing like a billion-plus dollar deal to make investors happy on a Monday. Source: BioSpace You Might Also Like Johnson & Johnson Forges Peptide Discovery Pact Worth $1.5 Billion With Japanese Biopharma Peptidream April 6, 2017 Counsyl Celebrates Anniversary With $80M Funding Round November 6, 2017 Aurora Diagnostics Inc. Acquires April 11, 2016
Johnson & Johnson Forges Peptide Discovery Pact Worth $1.5 Billion With Japanese Biopharma Peptidream April 6, 2017
